CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma

Trial Details

NCT ID

NCT06486337

Phase

PHASE2

Sponsor

The First Affiliated Hospital of Soochow University

Status

RECRUITING

Cancer Type

Lymphoma

Interventions

• CMOP±R

Locations (sample)

• Suzhou, Jiangsu, China|31.30408,120.59538

Key Eligibility Criteria

• Patients fully understand this study, voluntarily participate and sign the informed consent (ICF);
• Age: 18-75 years old;
• Expected survival time ≥ 3 months;
• Histopathologically diagnosed newly diagnosed non-Hodgkin's lymphoma;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.